Grants to USA and territories public and private entities, tribes, and faith and community-based organizations to create regional treatment centers for hemophilia and other blood disorders. Applicants are advised that required registrations may take up to a month to finalize. The purpose of the program is to improve access to coordinated, evidence-based care for patients with hemophilia and related bleeding or clotting disorders and their families.
The goal of HRSA-22-068 is to establish regional networks of hemophilia treatment centers (HTCs) to improve the health and well-being for children, youth, and adults with hemophilia and related bleeding disorders and clotting disorders.HRSA will fund up to eight recipients will be funded for HRSA-22-068, one recipient per region. The eight HRSA-designated Hemophilia Regions are:New England: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Puerto Rico, US Virgin IslandsMid-Atlantic: Delaware, DC, Maryland, Pennsylvania, Virginia, West VirginiaSoutheast: Alabama, Florida, Georgia, Mississippi, Kentucky, North Carolina, South Carolina, TennesseeGreat Lakes: Indiana, Michigan, OhioNorthern States: Illinois, Minnesota, North Dakota, South Dakota, WisconsinGreat Plains: Arkansas, Louisiana, Oklahoma, Texas, Iowa, Kansas, Missouri, NebraskaMountain States: Alaska, Idaho, Oregon, Washington, Arizona, Colorado, Montana, New Mexico, Utah, WyomingWestern States and Territory: California, Hawaii, Nevada, and the Pacific IslandsThe Hemophilia Regions are defined by HRSA using a combination of the Public Health Service Regions and similarity in numbers of patients and numbers of hemophilia treatment centers.Each recipient is expected to be responsible for identifying, establishing, and monitoring a network of HTCs in the region. In collaboration with the NHPCC, recipients are expected to provide monitoring oversight, technical assistance (TA), education, and quality improvement opportunities for HTC staff on staff development issues, best practices for disease management and evidence-informed treatment guidelines, and patient and family education.Program Objectives can be found on page 7 of the NOFO. See Attached Files, below.

Leave a Reply

Your email address will not be published.